BRIANNA OLSON: Open Payments
NPI 1932848090 · DICKINSON, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$858 in 54 payments from 14 companies in 2025. Trend: 2023 $594 · 2024 $423 · 2025 $858
Food & beverage: $858
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 14 | $189 |
| ABBVIE INC. | 14 | $159 |
| E.R. Squibb & Sons, L.L.C. | 3 | $119 |
| Novartis Pharmaceuticals Corporation | 6 | $105 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $74 |
| PFIZER INC. | 3 | $52 |
| Verona Pharma, Inc. | 2 | $33 |
| Neurocrine BioSciences, Inc. | 2 | $30 |
| Actelion Pharmaceuticals US, Inc. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $18 |
Products named: VRAYLAR, OTEZLA, LEQVIO, CAMZYOS, CAPLYTA, EVENITY, Ohtuvayre, NURTEC ODT.
Industry payments across ND — which companies pay providers there.
